We're excited to share our newly improved newsletter!
Stay informed with insights on longevity, healthspan, and more. Join a growing community focused on evidence-based science and healthier living.
Subscribe now: foundation.us20.list-manage.…
#Aging #Longevity #Biotech
Watch the latest episode of @juliankissa's podcast with @biogerontology, @geochurch, @aubreydegrey, and @M_S_Ringel. Topics covered include FDA interest in aging, #longevity escape velocity, AI and clinical trials, epigenetic reprogramming, and hype’s impact on public trust.
AI can find a new drug candidate in days. So why does it take years to reach you?
@biogerontology says people “overestimate the capabilities of AI and underestimate the complexity of biology.” For some conditions, trials still take a decade.
That gap is now on @OpenAI's radar. This week, it bought Orchestra Bio, which uses AI agents to keep drug programmes on track.
A day later, an @AgingCell study found that the postmenopausal ovary stays biologically active for decades rather than going dormant. We're only scratching the surface of #menopause: onlinelibrary.wiley.com/doi/…
Support our Invested in Her Campaign: longevity.foundation/investe…
At 2026 @ARDD_Meeting: @novonordisk and @EliLillyandCo reported GLP-1 users’ aging-clock readings ~2–3 years below placebo. @ARPA_H is testing semaglutide + two @FDA-approved drugs in adults 60+.
@techreview #longevity #aging
technologyreview.com/2026/10…
Peptides are being widely discussed, but how strong is the science?
Our latest Hype vs. Reality article explores GLP-1 medicines, separating established clinical evidence from promising but preliminary findings.
Read more: longevity.foundation/tpost/0…
#peptides #GLP1 #longevity
At @ARDD_Meeting 2026, the @FDA said #aging and #longevity will be included in its next regulatory science agenda. Officials discussed trials, biomarkers and collaboration.
Read the @LifespanRI article by @ArkadyMazin: lifespan.io/fda-leaders-name…
The Longevity Science Foundation retweeted
Day 1 of #ARDD2026 opens at Harvard. George Daley, Dean of Harvard Medical School, kicks off the 13th Aging Research & Drug Discovery Meeting. Full program: agingpharma.org/program2026
ARDD 2026 is here in Boston, Oct 1-3. Proud of our ties with @ARDD_Meeting: SAB members @biogerontology, @Dr_Bischof; grantee PI @ScheibyeKnudsen; founders Garri Zmudze & Sergey Jakimov (@hqlongevc); organizer @InSilicoMeds.
Register and learn more: agingpharma.org/
Peptides are everywhere in conversations about weight loss, recovery, skin health, metabolism, and #longevity. But what are they, really? Our article explores what #peptides are, how they work, and how to separate science from hype.
Read more: longevity.foundation/tpost/2…
Colleagues from @metabesity and @APACLongevity are hosting the 2026 Asia-Pacific Healthy Longevity International Summit, Oct 1-4 in Hong Kong, with 1,000+ attendees and speakers including our Scientific Advisors, @mkaeberlein and @AndreaBMaier. Learn more: apaclongevitysociety.org/#/m…
Six proteomic #aging clocks showed reductions in predicted biological age among rentosertib-treated participants in a Phase 2a trial of @InsilicoMedicine drug for IPF. Congratulations to Insilico CEO and our scientific advisor @biogerontology and the team! nature.com/articles/s41587-0…
For the first time, people 65+ outnumber children ≤5 worldwide, @axios reports. Longer lives are an achievement, but longer life does not always mean longer health. As populations age, investing in #healthspan is increasingly urgent.
axios.com/2026/09/03/older-a…
#aging #longevity
The @USC has received a $7.5M @NIH grant to establish GeroSCORE, advancing research into sex differences in #aging, including #menopause and brain aging.
Progress in the field is being made, but major gaps remain. Help fund women’s health research: longevity.foundation/investe…
Thank you for your support @LifespanNews! Learn more about our Invested in Her campaign: longevity.foundation/investe…
The Longevity Science Foundation (@longescience) is extending the deadline for its Invested in Her campaign to October 1, 2026, as they work to support early-stage research into ovarian aging and menopause.
👉 Read more: lifespan.io/invested-in-her-…
Endometriosis affects ~190 million people worldwide, yet diagnosis can take years, and major #research gaps remain. Why is it so difficult to diagnose and treat?
Our latest SLIC article explores #endometriosis: longevity.foundation/tpost/u…
A vaccine for cancer? Moderna and Merck’s personalized mRNA cancer vaccine, combined with Keytruda, has met key efficacy endpoints in a Phase III melanoma trial.
What does a “cancer vaccine” mean, and could it help prevent #cancer from returning?
longevity.foundation/tpost/t…
New deadline: October 1.
Invested in Her is raising $250,000 for research into ovarian #aging and #menopause. 100% of donations go directly to research.
Help close the research gap: longevity.foundation/investe…
Invested in Her brought together leaders in NYC to explore challenges facing women’s health and opportunities for change. We are raising $250,000 for research on ovarian #aging and #menopause, with donations going directly to research.
Recap: longevity.foundation/news/tp… #longevity
4 days left until Invested in Her in NYC with 10 seats remaining. On August 14 we bring together investors, clinicians, and advocates at 7 World Trade Center.
Register: longevity.foundation/iih26
Donations support our $250,000 campaign for research into ovarian aging and menopause
We're pleased to welcome J.P. Morgan Private Bank as a Gold Sponsor of Invested in Her, an event advancing women's health research on Aug 14th in NYC.
Register: longevity.foundation/iih26
Learn more: privatebank.jpmorgan.com/nam…
The agenda for Invested in Her event on 8/14 is live. Join us in NYC for an afternoon focused on advancing women's health.
Part of our Invested in Her campaign, the event supports research into #menopause and ovarian #aging. Only 85 seats are available.
longevity.foundation/iih26
























